{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:47:59Z","timestamp":1790214479470,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-24-CE15-2995-01"],"award-info":[{"award-number":["ANR-24-CE15-2995-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-24-CE-177220-01"],"award-info":[{"award-number":["ANR-24-CE-177220-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018703","name":"EC | Horizon Europe | Innovative Europe | HORIZON EUROPE European Innovation Council","doi-asserted-by":"publisher","award":["COMBO N\u25e6101135438"],"award-info":[{"award-number":["COMBO N\u25e6101135438"]}],"id":[{"id":"10.13039\/100018703","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["ImSuFun"],"award-info":[{"award-number":["ImSuFun"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    With a steady increase in the number of at-risk patients, invasive fungal infections now represent a significant public health problem. These infections, caused by major pathogens such as\n                    <jats:italic>Aspergillus, Candida, Cryptococcus<\/jats:italic>\n                    , and\n                    <jats:italic>Pneumocystis<\/jats:italic>\n                    , affect increasingly diverse patient profiles, primarily immunocompromised individuals, with mortality rates often exceeding 50%. Managing these patients remains challenging, as very few systemic antifungals are currently available, compounded by major resistance issues related to the overuse and misuse of these drugs in clinical practice and agriculture. Fortunately, the field of medical mycology has benefited in recent years from major advances in pathogen-directed therapies, including new compounds, repurposing, new formulations, and the identification of new specific fungal targets. Although most immunomodulatory strategies are far from being implemented in clinical practice, recent breakthroughs in translational research have provided unprecedented hope in developing host-directed approaches leveraging cellular aspects and humoral mediators of immunopathogenesis.\n                  <\/jats:p>","DOI":"10.1038\/s44321-026-00449-x","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T13:32:54Z","timestamp":1778333574000},"page":"2523-2529","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Innovation in antifungal therapy"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3821-1762","authenticated-orcid":false,"given":"Sarah","family":"Delli\u00e8re","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6265-7321","authenticated-orcid":false,"given":"Nicolas","family":"Papon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,9]]},"reference":[{"key":"449_CR1","doi-asserted-by":"publisher","first-page":"e393","DOI":"10.1016\/S1473-3099(17)30442-5","volume":"17","author":"D Armstrong-James","year":"2017","unstructured":"Armstrong-James D, Brown GD, Netea MG, Zelante T, Gresnigt MS, van deVeerdonk FL, Levitz SM (2017) Immunotherapeutic approaches to treatment of fungal diseases. Lancet Infect Dis 17:e393\u2013e402","journal-title":"Lancet Infect Dis"},{"key":"449_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/nrmicro732","volume":"1","author":"A Casadevall","year":"2003","unstructured":"Casadevall A, Pirofski L (2003) The damage-response framework of microbial pathogenesis. Nat Rev Microbiol 1:17\u201324","journal-title":"Nat Rev Microbiol"},{"key":"449_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41586-024-08419-4","volume":"638","author":"NT Case","year":"2025","unstructured":"Case NT, Gurr SJ, Fisher MC, Blehert DS, Boone C, Casadevall A, Chowdhary A, Cuomo CA, Currie CR, Denning DW et al (2025) Fungal impacts on Earth\u2019s ecosystems. Nature 638:49\u201357","journal-title":"Nature"},{"key":"449_CR4","doi-asserted-by":"publisher","first-page":"115007","DOI":"10.1016\/j.addr.2023.115007","volume":"200","author":"L Chen","year":"2023","unstructured":"Chen L, Zhang L, Xie Y, Wang Y, Tian X, Fang W, Xue X, Wang L (2023) Confronting antifungal resistance, tolerance, and persistence: advances in drug target discovery and delivery systems. Adv Drug Deliv Rev 200:115007","journal-title":"Adv Drug Deliv Rev"},{"key":"449_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac535","volume":"9","author":"TK Chen","year":"2022","unstructured":"Chen TK, Batra JS, Michalik DE, Casillas J, Patel R, Ruiz ME, Hara H, Patel B, Kadapakkam M, Ch\u2019Ng J et al (2022) Recombinant human granulocyte-macrophage colony-stimulating factor (rhu GM-CSF) as adjuvant therapy for invasive fungal diseases. Open Forum Infect Dis 9:ofac535","journal-title":"Open Forum Infect Dis"},{"key":"449_CR6","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.cell.2025.11.036","volume":"189","author":"X Chen","year":"2026","unstructured":"Chen X, Duan HD, Hoy MJ, Koteva K, Spitzer M, Guitor AK, Puumala E, Fiebig AA, Hu G, Yiu B et al (2026) Butyrolactol A enhances caspofungin efficacy via flippase inhibition in drug-resistant fungi. Cell 189:620\u2013639.e28","journal-title":"Cell"},{"key":"449_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s40588-025-00249-w","volume":"12","author":"A Curtis","year":"2025","unstructured":"Curtis A, Oladimeji F, Kavanagh K (2025) Models for studying fungal pathogenesis. Curr Clin Microbiol Rep 12:12","journal-title":"Curr Clin Microbiol Rep"},{"key":"449_CR8","doi-asserted-by":"crossref","unstructured":"Delli\u00e8re S, Aimanianda V (2023) Humoral immunity against Aspergillus fumigatus. Mycopathologia 188:603\u2013621","DOI":"10.1007\/s11046-023-00742-0"},{"key":"449_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.mib.2020.05.005","volume":"58","author":"S Delli\u00e8re","year":"2020","unstructured":"Delli\u00e8re S, Wong SSW, Aimanianda V (2020) Soluble mediators in anti-fungal immunity. Curr Opin Microbiol 58:24\u201331","journal-title":"Curr Opin Microbiol"},{"key":"449_CR10","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41586-025-08678-9","volume":"640","author":"Q Deng","year":"2025","unstructured":"Deng Q, Li Y, He W, Chen T, Liu N, Ma L, Qiu Z, Shang Z, Wang Z (2025) A polyene macrolide targeting phospholipids in the fungal cell membrane. Nature 640:743\u2013751","journal-title":"Nature"},{"key":"449_CR11","doi-asserted-by":"crossref","unstructured":"Denning DW (2024) Global incidence and mortality of severe fungal disease. Lancet Infect Dis 24:e428\u2013e438","DOI":"10.1016\/S1473-3099(23)00692-8"},{"key":"449_CR12","unstructured":"Division WAR (2022) WHO fungal priority pathogens list to guide research, development and public health action. World Health Organization, Geneva"},{"key":"449_CR13","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1093\/cid\/ciy185","volume":"66","author":"JE Edwards Jr","year":"2018","unstructured":"Edwards JE Jr, Schwartz MM, Schmidt CS, Sobel JD, Nyirjesy P, Schodel F, Marchus E, Lizakowski M, DeMontigny EA, Hoeg J et al (2018) A fungal immunotherapeutic vaccine (NDV-3A) for treatment of recurrent vulvovaginal candidiasis\u2014a phase 2 randomized, double-blind, placebo-controlled trial. Clin Infect Dis 66:1928\u20131936","journal-title":"Clin Infect Dis"},{"key":"449_CR14","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41579-022-00720-1","volume":"20","author":"MC Fisher","year":"2022","unstructured":"Fisher MC, Alastruey-Izquierdo A, Berman J, Bicanic T, Bignell EM, Bowyer P, Bromley M, Br\u00fcggemann R, Garber G, Cornely OA et al (2022) Tackling the emerging threat of antifungal resistance to human health. Nat Rev Microbiol 20:557\u2013571","journal-title":"Nat Rev Microbiol"},{"key":"449_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-1-0716-3199-7_7","volume":"2667","author":"MS Fu","year":"2023","unstructured":"Fu MS, Kawakami K, Drummond RA (2023) Antifungal immunity, methods and protocols. Methods Mol Biol 2667:99\u2013112","journal-title":"Methods Mol Biol"},{"key":"449_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16120-z","volume":"11","author":"SM Gon\u00e7alves","year":"2020","unstructured":"Gon\u00e7alves SM, Duarte-Oliveira C, Campos CF, Aimanianda V, ter Horst R, Leite L, Mercier T, Pereira P, Fern\u00e1ndez-Garc\u00eda M, Antunes D et al (2020) Phagosomal removal of fungal melanin reprograms macrophage metabolism to promote antifungal immunity. Nat Commun 11:2282","journal-title":"Nat Commun"},{"key":"449_CR17","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ads7369","volume":"17","author":"Y Gu","year":"2025","unstructured":"Gu Y, Singh S, Alqarihi A, Alkhazraji S, Gebremariam T, Youssef EG, Liu H, Fan X, Jiang W-R, Andes D et al (2025) A humanized antibody against mucormycosis targets angioinvasion and augments the host immune response. Sci Transl Med 17:eads7369","journal-title":"Sci Transl Med"},{"key":"449_CR18","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3390\/jof11070539","volume":"11","author":"AT Harding","year":"2025","unstructured":"Harding AT, Gehrke L, Vyas JM, Harding HB (2025) Human brain organoids: a new model to study Cryptococcus neoformans neurotropism. J Fungi 11:539","journal-title":"J Fungi"},{"key":"449_CR19","doi-asserted-by":"crossref","unstructured":"Hoenigl M, Arastehfar A, Arendrup MC, Br\u00fcggemann R, Carvalho A, Chiller T, Chen S, Egger M, Feys S, Gangneux J-P et al (2024) Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease. Clin Microbiol Rev 37:e0007423","DOI":"10.1128\/cmr.00074-23"},{"key":"449_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2026.117106","volume":"45","author":"J Huang","year":"2026","unstructured":"Huang J, Wang Y, Li F, Zhang N, Tian G, Guo D, Guo Y, Liu Z, Wu Y, Li X et al (2026) Scap stabilizes PKM2 to promote glycolysis and enhance anti-fungal immunity in macrophages. Cell Rep 45:117106","journal-title":"Cell Rep"},{"key":"449_CR21","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/s41551-021-00743-8","volume":"5","author":"J Kim","year":"2021","unstructured":"Kim J, Lee K-T, Lee JS, Shin J, Cui B, Yang K, Choi YS, Choi N, Lee SH, Lee J-H et al (2021) Fungal brain infection modelled in a human-neurovascular-unit-on-a-chip with a functional blood\u2013brain barrier. Nat Biomed Eng 5:830\u2013846","journal-title":"Nat Biomed Eng"},{"key":"449_CR22","doi-asserted-by":"publisher","first-page":"fuab005","DOI":"10.1093\/femsre\/fuab005","volume":"45","author":"A Last","year":"2021","unstructured":"Last A, Maurer M, Mosig AS, Gresnigt MS, Hube B (2021) In vitro infection models to study fungal\u2013host interactions. FEMS Microbiol Rev 45:fuab005","journal-title":"FEMS Microbiol Rev"},{"key":"449_CR23","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41577-022-00826-w","volume":"23","author":"MS Lionakis","year":"2023","unstructured":"Lionakis MS, Drummond RA, Hohl TM (2023) Immune responses to human fungal pathogens and therapeutic prospects. Nat Rev Immunol 23:433\u2013452","journal-title":"Nat Rev Immunol"},{"key":"449_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adw8481","volume":"18","author":"J Liu","year":"2026","unstructured":"Liu J, Ding H, Tan W, Yu R, Li Y, Liu Y, Liu M, Zhao P, Liu Y, Xu F et al (2026) Meteorin-like is associated with poor outcome in invasive candidiasis in mouse models and in humans. Sci Transl Med 18:eadw8481","journal-title":"Sci Transl Med"},{"key":"449_CR25","doi-asserted-by":"crossref","unstructured":"Maji A, Soutar CP, Zhang J, Lewandowska A, Uno BE, Yan S, Shelke Y, Murhade G, Nimerovsky E, Borcik CG et al (2023) Tuning sterol extraction kinetics yields a renal-sparing polyene antifungal. Nature 623:1079\u20131085","DOI":"10.1038\/s41586-023-06710-4"},{"key":"449_CR26","doi-asserted-by":"crossref","unstructured":"Manchon R, Feys S, Hoenigl M, van de Veerdonk FL, Lanternier F, Wauters J, Carvalho A, Serris A, Delli\u00e8re S (2026) Aspergillus and host-pathogen interaction: focus on treatment-relevant aspects. Clin Microbiol Infect 32:729\u2013739","DOI":"10.1016\/j.cmi.2025.08.030"},{"key":"449_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2024.116653","volume":"111","author":"R Mhenni","year":"2024","unstructured":"Mhenni R, Delli\u00e8re S, Maaouia CB, Hamane S, Deniau B, Mah\u00e9vas T, Chaussard M, Coutrot M, Guillemet L, Cupaciu A et al (2024) Combined antifungal therapy with immunostimulation for refractory cutaneous and peritoneal mucormycosis caused by Rhizopus microsporus. Diagn Microbiol Infect Dis 111:116653","journal-title":"Diagn Microbiol Infect Dis"},{"key":"449_CR28","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.1038\/s44321-025-00340-1","volume":"17","author":"G Middleton","year":"2025","unstructured":"Middleton G, Mahamud FO, Storer ISR, Williams-Gunn A, Wostear F, Abdolrasouli A, Barclay E, Bradford A, Steward O, Schelenz S et al (2025) Evidence that G-quadruplexes form in pathogenic fungi and represent promising antifungal targets. EMBO Mol Med 17:3636\u20133656","journal-title":"EMBO Mol Med"},{"key":"449_CR29","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1046\/j.1469-0691.2003.00694.x","volume":"9","author":"L Mouthon","year":"2003","unstructured":"Mouthon L, Lortholary O (2003) Intravenous immunoglobulins in infectious diseases: where do we stand? Clin Microbiol Infect 9:333\u2013338","journal-title":"Clin Microbiol Infect"},{"key":"449_CR30","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.tips.2025.04.004","volume":"46","author":"N Papon","year":"2025","unstructured":"Papon N, Courdavault V, Chaturvedi V (2025) Phylogeny-guided discovery of new antifungals. Trends Pharm Sci 46:483\u2013485","journal-title":"Trends Pharm Sci"},{"key":"449_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-62572-6","volume":"16","author":"C P\u00e9rez-Arques","year":"2025","unstructured":"P\u00e9rez-Arques C, Navarro-Mendoza MI, Xu Z, Walther G, Heitman J (2025) RNAi epimutations conferring antifungal drug resistance are inheritable. Nat Commun 16:7293","journal-title":"Nat Commun"},{"key":"449_CR32","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-025-09882-3","volume":"649","author":"A Pikoulas","year":"2026","unstructured":"Pikoulas A, Morianos I, Nidris V, Hamdy R, Intze E, L\u00f3pez-L\u00f3pez \u00c1, Moran-Garrido M, Muthu V, Halabalaki M, Papaioanou V et al (2026) Albumin orchestrates a natural host defence mechanism against mucormycosis. Nature 649:693\u2013702","journal-title":"Nature"},{"key":"449_CR33","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s41564-022-01183-z","volume":"7","author":"SJ Priest","year":"2022","unstructured":"Priest SJ, Yadav V, Roth C, Dahlmann TA, K\u00fcck U, Magwene PM, Heitman J (2022) Uncontrolled transposition following RNAi loss causes hypermutation and antifungal drug resistance in clinical isolates of Cryptococcus neoformans. Nat Microbiol 7:1239\u20131251","journal-title":"Nat Microbiol"},{"key":"449_CR34","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1093\/annonc\/mdt110","volume":"24","author":"II Raad","year":"2013","unstructured":"Raad II, Chaftari AM, Shuaibi MMA, Jiang Y, Shomali W, Cortes JE, Lichtiger B, Hachem RY (2013) Granulocyte transfusions in hematologic malignancy patients with invasive pulmonary aspergillosis: outcomes and complications. Ann Oncol 24:1873\u20131879","journal-title":"Ann Oncol"},{"key":"449_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202509567","volume":"12","author":"CA Roque-Borda","year":"2025","unstructured":"Roque-Borda CA, Medina-Alarc\u00f3n KP, Pereira JPSG, dos A Sevilhano TC, Aguilar-Mor\u00f3n B, D\u00edaz-C\u00e1rdenas F, da Cruz LS, Xavier-J\u00fanior FH, Vicente EF, Perdig\u00e3o J et al (2025) Repositioning antimicrobial peptides against WHO-priority fungi. Adv Sci 12:e09567","journal-title":"Adv Sci"},{"key":"449_CR36","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.12688\/f1000research.125074.2","volume":"11","author":"D Ruhluel","year":"2022","unstructured":"Ruhluel D, O\u2019Brien S, Fothergill JL, Neill DR (2022) Development of liquid culture media mimicking the conditions of sinuses and lungs in cystic fibrosis and health. F1000Research 11:1007","journal-title":"F1000Research"},{"key":"449_CR37","doi-asserted-by":"crossref","unstructured":"Salmanton-Garc\u00eda J, Hoenigl M, Gangneux J-P, Segal E, Alastruey-Izquierdo A, Akdagli SA, Lagrou K, \u00d6zenci V, Vena A, Cornely OA (2022) The current state of laboratory mycology and access to antifungal treatment in Europe: a European Confederation of Medical Mycology survey. Lancet Microbe 4:e47\u2013e56","DOI":"10.1016\/S2666-5247(22)00261-0"},{"key":"449_CR38","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1126\/science.adf8972","volume":"381","author":"DJ Santana","year":"2023","unstructured":"Santana DJ, Anku JAE, Zhao G, Zarnowski R, Johnson CJ, Hautau H, Visser ND, Ibrahim AS, Andes D, Nett JE et al (2023) A Candida auris-specific adhesin, Scf1, governs surface association, colonization, and virulence. Science 381:1461\u20131467","journal-title":"Science"},{"key":"449_CR39","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abq6682","volume":"14","author":"N Sarden","year":"2022","unstructured":"Sarden N, Sinha S, Potts KG, Pernet E, Hiroki CH, Hassanabad MF, Nguyen AP, Lou Y, Farias R, Winston BW et al (2022) A B1a\u2013natural IgG\u2013neutrophil axis is impaired in viral- and steroid-associated aspergillosis. Sci Transl Med 14:eabq6682","journal-title":"Sci Transl Med"},{"key":"449_CR40","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abh1209","volume":"14","author":"M Seif","year":"2022","unstructured":"Seif M, Kakoschke TK, Ebel F, Bellet MM, Trinks N, Renga G, Pariano M, Romani L, Tappe B, Espie D et al (2022) CAR T cells targeting Aspergillus fumigatus are effective at treating invasive pulmonary aspergillosis in preclinical models. Sci Transl Med 14:eabh1209","journal-title":"Sci Transl Med"},{"key":"449_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.900522","volume":"13","author":"A Serris","year":"2022","unstructured":"Serris A, Ouedrani A, Uhel F, Gazzano M, Bedarida V, Rouzaud C, Bougnoux M-E, Raphalen J-H, Poir\u00e9e S, Lambotte O et al (2022) Case Report: immune checkpoint blockade plus interferon-\u0393 add-on antifungal therapy in the treatment of refractory covid-associated pulmonary aspergillosis and cerebral mucormycosis. Front Immunol 13:900522","journal-title":"Front Immunol"},{"key":"449_CR42","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41564-020-00837-0","volume":"6","author":"SSM Soliman","year":"2021","unstructured":"Soliman SSM, Baldin C, Gu Y, Singh S, Gebremariam T, Swidergall M, Alqarihi A, Youssef EG, Alkhazraji S, Pikoulas A et al (2021) Mucoricin is a ricin-like toxin that is critical for the pathogenesis of mucormycosis. Nat Microbiol 6:313\u2013326","journal-title":"Nat Microbiol"},{"key":"449_CR43","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/JLB.4HI1221-722R","volume":"111","author":"DB Sykes","year":"2022","unstructured":"Sykes DB, Martinelli MM, Negoro P, Xu S, Maxcy K, Timmer K, Viens AL, Alexander NJ, Atallah J, Snarr BD et al (2022) Transfusable neutrophil progenitors as cellular therapy for the prevention of invasive fungal infections. J Leukoc Biol 111:1133\u20131145","journal-title":"J Leukoc Biol"},{"key":"449_CR44","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/infdis\/jiaf209","volume":"232","author":"AM Tatara","year":"2025","unstructured":"Tatara AM, Mikos AG, Kontoyiannis DP (2025) Immunoengineering: an emerging field in infectious diseases. J Infect Dis 232:28\u201335","journal-title":"J Infect Dis"},{"key":"449_CR45","doi-asserted-by":"publisher","first-page":"e00225","DOI":"10.1128\/aac.00225-25","volume":"69","author":"R Vahedi-Shahandashti","year":"2025","unstructured":"Vahedi-Shahandashti R, Hofer I, Leighton H, Fothergill JL, Neill DR, Lass-Fl\u00f6rl C (2025) The impact of respiratory tract mimicking media on antifungal susceptibility testing. Antimicrob Agents Chemother 69:e00225","journal-title":"Antimicrob Agents Chemother"},{"key":"449_CR46","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1038\/s41564-025-02055-y","volume":"10","author":"N van Rhijn","year":"2025","unstructured":"van Rhijn N, Rhodes J (2025) Evolution of antifungal resistance in the environment. Nat Microbiol 10:1804\u20131815","journal-title":"Nat Microbiol"},{"key":"449_CR47","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.1200\/JCO.2014.60.5121","volume":"33","author":"L Wan","year":"2015","unstructured":"Wan L, Zhang Y, Lai Y, Jiang M, Song Y, Zhou J, Zhang Z, Duan X, Fu Y, Liao L et al (2015) Effect of granulocyte-macrophage colony-stimulating factor on prevention and treatment of invasive fungal disease in recipients of allogeneic stem-cell transplantation: a prospective multicenter randomized phase IV trial. J Clin Oncol 33:3999\u20134006","journal-title":"J Clin Oncol"},{"key":"449_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03330-y","volume":"12","author":"X Wang","year":"2021","unstructured":"Wang X, Wang S, Guo B, Su Y, Tan Z, Chang M, Diao J, Zhao Y, Wang Y (2021) Human primary epidermal organoids enable modeling of dermatophyte infections. Cell Death Dis 12:35","journal-title":"Cell Death Dis"},{"key":"449_CR49","doi-asserted-by":"publisher","first-page":"e00171","DOI":"10.1128\/mmbr.00171-22","volume":"88","author":"H Weerasinghe","year":"2024","unstructured":"Weerasinghe H, St\u00f6lting H, Rose AJ, Traven A (2024) Metabolic homeostasis in fungal infections from the perspective of pathogens, immune cells, and whole-body systems. Microbiol Mol Biol Rev 88:e00171\u201322","journal-title":"Microbiol Mol Biol Rev"},{"key":"449_CR50","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.chom.2024.09.011","volume":"32","author":"AJ Whitehead","year":"2024","unstructured":"Whitehead AJ, Woodring T, Klein BS (2024) Immunity to fungi and vaccine considerations. Cell Host Microbe 32:1681\u20131690","journal-title":"Cell Host Microbe"},{"key":"449_CR51","doi-asserted-by":"publisher","first-page":"114967","DOI":"10.1016\/j.addr.2023.114967","volume":"199","author":"S Wu","year":"2023","unstructured":"Wu S, Song R, Liu T, Li C (2023) Antifungal therapy: novel drug delivery strategies driven by new targets. Adv Drug Deliv Rev 199:114967","journal-title":"Adv Drug Deliv Rev"},{"key":"449_CR52","doi-asserted-by":"publisher","first-page":"1018202","DOI":"10.3389\/fimmu.2022.1018202","volume":"13","author":"S Wurster","year":"2022","unstructured":"Wurster S, Watowich SS, Kontoyiannis DP (2022) Checkpoint inhibitors as immunotherapy for fungal infections: promises, challenges, and unanswered questions. Front Immunol 13:1018202","journal-title":"Front Immunol"},{"key":"449_CR53","doi-asserted-by":"crossref","unstructured":"Zhai B, Liao C, Jaggavarapu S, Tang Y, Rolling T, Ning Y, Sun T, Bergin SA, Gjonbalaj M, Miranda E et al (2024) Antifungal heteroresistance causes prophylaxis failure and facilitates breakthrough Candida parapsilosis infections. Nat Med 30:3163\u20133172","DOI":"10.1038\/s41591-024-03183-4"},{"key":"449_CR54","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1126\/science.abd6919","volume":"370","author":"F Zhang","year":"2020","unstructured":"Zhang F, Zhao M, Braun DR, Ericksen SS, Piotrowski JS, Nelson J, Peng J, Ananiev GE, Chanana S, Barns K et al (2020) A marine microbiome antifungal targets urgent-threat drug-resistant fungi. Science 370:974\u2013978","journal-title":"Science"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00449-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-026-00449-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00449-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:31:19Z","timestamp":1783924279000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-026-00449-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":54,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,13]]}},"alternative-id":["449"],"URL":"https:\/\/doi.org\/10.1038\/s44321-026-00449-x","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,9]]},"assertion":[{"value":"11 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}